Wai Chun Bio-Technology Investor Relations Material
Latest events
H1 2025
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Wai Chun Bio-Technology Limited
Access all reports
Wai Chun Bio-Technology Limited is a Hong Kong-based investment holding company engaged in the trading and distribution of modified starch and other biochemical products. The company’s operations include sourcing, processing, and selling agricultural and industrial-grade starch products used in food processing, paper manufacturing, textiles, and other industrial applications. Wai Chun Bio-Technology also explores opportunities in related sectors to diversify its business portfolio. The company is headquartered in Hong Kong, and its shares are listed on the HKEX.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
660
Country
🇭🇰 Hong Kong